|
⚲
|
| Keyboard |
| Cannon Michael D
✚
|
|
|---|---|
| CIK # | 0001203602 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001203602] | |
| 4 | [0001203602] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Moleculin Biotech Inc | |
| Cannon Michael D | |
| Kinex Pharmaceuticals LLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Moleculin Biotech Inc MBRX
Stock Options (right to buy) · derivative
|
2025-11-12 | Grant | 150,000 | ||
|
Moleculin Biotech Inc MBRX
Stock option (right to buy) · derivative
|
2024-11-04 | Grant | 10,000 | ||
|
Moleculin Biotech Inc MBRX
Stock option (right to buy) · derivative
|
2023-05-25 | Grant | 15,000 | ||
|
Moleculin Biotech Inc MBRX
Stock option (right to buy) · derivative
|
2022-06-20 | Grant | 23,333 | ||
|
Moleculin Biotech Inc MBRX
Stock option (right to buy) · derivative
|
2022-06-20 | Grant | 15,000 | ||
|
Moleculin Biotech Inc MBRX
Stock option (right to buy) · derivative
|
2021-06-07 | Grant | 10,000 | ||
|
Moleculin Biotech Inc MBRX
Stock option (right to buy) · derivative
|
2020-06-15 | Grant | 15,000 | ||
|
Moleculin Biotech Inc MBRX
Stock option (right to buy) · derivative
|
2019-07-11 | Grant | 35,000 | ||
|
Moleculin Biotech Inc MBRX
Stock option (right to buy) · derivative
|
2019-05-22 | Grant | 15,000 | ||
|
Moleculin Biotech Inc MBRX
Stock option (right to buy) · derivative
|
2018-06-06 | Grant | 35,000 | ||
|
Moleculin Biotech Inc MBRX
Option to purchase common stock · derivative
|
2017-07-24 | Grant | 15,000 | ||
|
Kinex Pharmaceuticals LLC ATNX
Stock Option (Right to Buy) · derivative
|
2017-06-19 | Grant | 18,000 | $0.00 | |
|
Moleculin Biotech Inc MBRX
Option to purchase common stock · derivative
|
2016-09-23 | Grant | 20,000 |